tiprankstipranks
Trending News
More News >
Natural Alternatives International (NAII)
NASDAQ:NAII

Natural Alternatives International (NAII) AI Stock Analysis

Compare
85 Followers

Top Page

NAII

Natural Alternatives International

(NASDAQ:NAII)

Select Model
Select Model
Select Model
Neutral 47 (OpenAI - 4o)
Rating:47Neutral
Price Target:
$3.00
▼(-4.76% Downside)
The overall stock score of 47 reflects significant financial challenges, including declining profitability and cash flow issues, which are the most impactful factors. Technical analysis shows mixed signals, and valuation is unattractive due to ongoing losses. The resolution of credit agreement issues provides some stability but does not offset the broader financial concerns.
Positive Factors
Revenue Growth
Positive revenue growth suggests the company is expanding its market presence and product demand, which is critical for long-term success.
Credit Agreement Resolution
Resolving credit agreement issues ensures financial stability and supports ongoing operations, reducing financial uncertainty.
Strategic Partnerships
Strategic partnerships enhance product development and market reach, strengthening competitive positioning and innovation capabilities.
Negative Factors
Declining Profitability
Negative profitability margins indicate challenges in cost management and pricing power, affecting long-term financial health.
Increasing Leverage
Higher leverage can strain financial flexibility and increase risk, potentially impacting the company's ability to invest in growth.
Cash Flow Challenges
Weak cash flow generation limits the company's ability to fund operations and invest in future growth, posing liquidity risks.

Natural Alternatives International (NAII) vs. SPDR S&P 500 ETF (SPY)

Natural Alternatives International Business Overview & Revenue Model

Company DescriptionNatural Alternatives International (NAII) is a leading provider of contract manufacturing services and nutritional products, specializing in the development and production of innovative dietary supplements and functional foods. The company operates primarily in the health and wellness sector, focusing on high-quality, science-based formulations that cater to the growing demand for natural and organic products. NAII's core offerings include a diverse range of nutritional supplements, private label products, and custom formulations for various clients across the globe, emphasizing quality and compliance with industry standards.
How the Company Makes MoneyNatural Alternatives International generates revenue through several key streams, primarily from its contract manufacturing services, where it partners with brands to produce dietary supplements and functional foods under private labels. The company also earns income from the sale of its proprietary products, which are marketed directly to consumers and distributors. Additionally, NAII benefits from strategic partnerships with health and wellness brands that enable collaborative product development, leveraging its expertise in formulation and manufacturing. The company's focus on quality, compliance, and innovation has positioned it favorably in a competitive market, driving consistent revenue growth.

Natural Alternatives International Key Performance Indicators (KPIs)

Any
Any
Revenue by Segment
Revenue by Segment
Chart Insights
Data provided by:The Fly

Natural Alternatives International Financial Statement Overview

Summary
Natural Alternatives International is facing financial challenges, with declining profitability and increasing leverage. While there is some revenue growth, the negative margins and cash flow issues highlight the need for strategic improvements to stabilize the company's financial health.
Income Statement
45
Neutral
Natural Alternatives International has experienced declining profitability with negative net profit and EBIT margins in the TTM period. The revenue growth rate is positive at 3.53%, indicating some recovery, but the overall margins remain weak compared to previous years, highlighting challenges in maintaining profitability.
Balance Sheet
50
Neutral
The company's debt-to-equity ratio has increased over time, indicating higher leverage, which could pose risks if not managed properly. Return on equity is negative, reflecting recent losses. However, the equity ratio remains relatively stable, suggesting a balanced asset structure.
Cash Flow
40
Negative
The cash flow situation is concerning, with a significant decline in free cash flow growth and a low operating cash flow to net income ratio. Although there is some operating cash flow, the negative free cash flow growth indicates potential liquidity challenges.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue130.58M129.86M113.80M154.01M170.97M178.52M
Gross Profit10.56M9.29M6.87M18.16M30.51M30.44M
EBITDA-3.53M-2.70M-4.46M11.09M20.66M16.58M
Net Income-18.81M-13.57M-7.22M2.52M10.71M10.77M
Balance Sheet
Total Assets151.94M151.94M162.34M134.15M146.00M120.28M
Cash, Cash Equivalents and Short-Term Investments12.32M12.32M11.98M13.60M21.83M32.13M
Total Debt59.03M59.03M60.29M30.93M31.84M16.48M
Total Liabilities83.51M83.51M79.75M45.38M57.48M40.20M
Stockholders Equity68.43M68.43M82.59M88.77M88.52M80.08M
Cash Flow
Free Cash Flow7.95M2.32M-4.51M-6.50M-14.62M15.70M
Operating Cash Flow12.72M5.93M-1.50M7.02M11.87M20.81M
Investing Cash Flow-4.77M-3.61M-3.02M-13.47M-26.46M-5.04M
Financing Cash Flow-4.07M-1.97M2.89M-1.78M4.29M-14.11M

Natural Alternatives International Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price3.15
Price Trends
50DMA
3.04
Positive
100DMA
3.23
Negative
200DMA
3.27
Negative
Market Momentum
MACD
0.01
Positive
RSI
49.92
Neutral
STOCH
32.63
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NAII, the sentiment is Neutral. The current price of 3.15 is below the 20-day moving average (MA) of 3.35, above the 50-day MA of 3.04, and below the 200-day MA of 3.27, indicating a neutral trend. The MACD of 0.01 indicates Positive momentum. The RSI at 49.92 is Neutral, neither overbought nor oversold. The STOCH value of 32.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for NAII.

Natural Alternatives International Risk Analysis

Natural Alternatives International disclosed 22 risk factors in its most recent earnings report. Natural Alternatives International reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Natural Alternatives International Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$389.10M27.419.52%6.62%-7.85%
71
Outperform
$158.52M24.2717.77%12.44%-20.33%
66
Neutral
$78.75M8.0533.31%2.82%16.77%143.30%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
61
Neutral
$364.15M22.383.20%5.88%-68.62%
47
Neutral
$19.83M-1.64-15.93%18.19%-35.22%
42
Neutral
$106.87M-0.20-75.51%-10.13%-532.32%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NAII
Natural Alternatives International
3.21
-0.94
-22.65%
NATR
Nature's Sunshine Products
22.24
7.09
46.80%
HAIN
Hain Celestial
1.18
-5.31
-81.82%
USNA
USANA Health
19.92
-14.02
-41.31%
LFVN
LifeVantage
6.20
-9.89
-61.47%
FTLF
FitLife Brands
16.88
0.76
4.71%

Natural Alternatives International Corporate Events

Private Placements and FinancingRegulatory Filings and Compliance
Natural Alternatives Resolves Credit Agreement Issues
Positive
Dec 17, 2025

Natural Alternatives International, Inc. announced that it failed to comply with certain financial covenants under its Credit Agreement with Wells Fargo Bank for its fiscal first quarter ending September 30, 2025. To address the issue, the company successfully negotiated a Waiver and Release Agreement with Wells Fargo on December 17, 2025, ensuring that all defaults were waived and the Credit Agreement remains fully operational. This resolution reinforces the company’s ability to maintain its financial arrangements and supports its ongoing operations, bringing stability for stakeholders moving forward.

Executive/Board ChangesShareholder Meetings
Natural Alternatives International Holds Annual Stockholder Meeting
Neutral
Dec 12, 2025

On December 5, 2025, Natural Alternatives International held its Annual Meeting of Stockholders where several key decisions were made. The stockholders approved the election of a Class II director, the First Amendment to the 2020 Omnibus Equity Incentive Plan, the ratification of Haskell & White LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2026, the compensation of the company’s named executive officers, and a three-year frequency for non-binding votes on executive compensation.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 19, 2025